| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Manager, Arc Division | Snr VP, R& D and Regulatory | Snr VP, Research & Development
2 companies
Ofir Koren is Snr VP, R& D and Regulatory at LFWD, with reported holdings spanning 2 companies. Ofir Koren's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $402K at current prices.
Ofir Koren's largest disclosed position is in LFWD as Snr VP, R& D and Regulatory, worth about $394K. The LFWD filings lean toward selling, a net 5,578 shares.
Ofir Koren has 9 Form 4 filings on record from May 2016 to October 2026, across 2 companies: General Manager, Arc Division at Nano-X Imaging (NNOX), 2026; Snr VP, R & D and Regulatory at Lifeward (LFWD), 2016–2020.
The 20 reported transactions were 7 stock awards, 5 open-market sales, 3 option or other derivative awards and 3 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $20K.
The largest open-market sale was 5,220 shares of LFWD at an average $3.45 on January 6, 2017, about $18K.